Radiosensitivity enhancement by combined treatment of nimotuzumab and celecoxib on nasopharyngeal carcinoma cells

INTRODUCTION: In this study, the radiation-enhancing effects of combined treatment with nimotuzumab, a humanized EGFR-blocking antibody, and celecoxib, a COX-2 selective inhibitor, in human nasopharyngeal carcinoma (NPC) cells were investigated. MATERIALS AND METHODS: 3-(4,5-Dimethylthiazol-2yl)-2,5...

Descripción completa

Detalles Bibliográficos
Autores principales: Huang, Jianfeng, Yuan, Xiaopeng, Pang, Qingfeng, Zhang, Haowen, Yu, Jiahua, Yang, Bo, Zhou, Leyuan, Zhang, Fuzheng, Liu, Fenju
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2018
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6052925/
https://www.ncbi.nlm.nih.gov/pubmed/30038488
http://dx.doi.org/10.2147/DDDT.S163595

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6052925/
https://www.ncbi.nlm.nih.gov/pubmed/30038488
http://dx.doi.org/10.2147/DDDT.S163595

Ejemplares similares